Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum

Publication date

2023-08-29

Authors

Kirkels, F P
van Osta, Nick
Rootwelt-Norberg, Christine
Chivulescu, Monica
van Loon, Tim
Aabel, Eivind W
Castrini, Anna I
Lie, Øyvind H
Asselbergs, Folkert WORCID 0000-0002-1692-8669ISNI 0000000391548591
Delhaas, Tammo

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement of primarily the right ventricular myocardium, a substrate for life-threatening ventricular arrhythmias (VAs). Repeated cardiac imaging of at-risk relatives is important for early disease detection. However, it is not known whether screening should be age-tailored. Objectives: The goal of this study was to assess the need for age-tailoring of follow-up protocols in early ARVC by evaluating myocardial disease progression in different age groups. Methods: We divided patients with early-stage ARVC and genotype-positive relatives without overt structural disease and VA at first evaluation into 3 groups: age <30 years, 30 to 50 years, and ≥50 years. Longitudinal biventricular deformation characteristics were used to monitor disease progression. To link deformation abnormalities to underlying myocardial disease substrates, Digital Twins were created using an imaging-based computational modeling framework. Results: We included 313 echocardiographic assessments from 82 subjects (57% female, age 39 ± 17 years, 10% probands) during 6.7 ± 3.3 years of follow-up. Left ventricular global longitudinal strain slightly deteriorated similarly in all age groups (0.1%-point per year [95% CI: 0.05-0.15]). Disease progression in all age groups was more pronounced in the right ventricular lateral wall, expressed by worsening in longitudinal strain (0.6%-point per year [95% CI: 0.46-0.70]) and local differences in myocardial contractility, compliance, and activation delay in the Digital Twin. Six patients experienced VA during follow-up. Conclusions: Disease progression was similar in all age groups, and sustained VA also occurred in patients aged >50 years without overt ARVC phenotype at first evaluation. Unlike recommended by current guidelines, our study suggests that follow-up of ARVC patients and relatives should not stop at older age.

Keywords

ARVC, Digital Twin, arrhythmogenic cardiomyopathy, deformation imaging, early detection, family screening, Cardiology and Cardiovascular Medicine

Citation

Kirkels, F P, van Osta, N, Rootwelt-Norberg, C, Chivulescu, M, van Loon, T, Aabel, E W, Castrini, A I, Lie, Ø H, Asselbergs, F W, Delhaas, T, Cramer, M J, Teske, A J, Haugaa, K H & Lumens, J 2023, 'Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum', Journal of the American College of Cardiology, vol. 82, no. 9, pp. 785-797. https://doi.org/10.1016/j.jacc.2023.05.065